Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. .94學年度
  5. 探討氧化膽固醇促進人類臍帶靜脈內皮細胞血管新生之作用與機轉
 
  • Details
Options

探討氧化膽固醇促進人類臍帶靜脈內皮細胞血管新生之作用與機轉

Other Title
Mechanism of oxysterol-induced angiogenesis on human umbilical vein endothelial cells
Type
thesis
Date Issued
2006
Author(s)
施怡伶
Advisor
蕭哲志
Subjects
系所名稱:藥理學研究所
Abstract
在動物及人體組織中含有大量形成細胞膜主要成分之膽固醇,膽固醇在體內(in vivo)轉化成膽酸及荷爾蒙的過程會被氧化形成氧化性膽固醇;在活體外,當膽固醇受到加熱、空氣、光及一些氧化劑時亦會被氧化形成氧化性膽固醇。氧化性膽固醇在動脈粥樣化(atherogenesis)、細胞毒性(cytotoxicity)、致突變性(mutagenesis) and致癌性(carcinogenesis)扮演很重要的角色。許多文獻中都指出粥狀動脈硬化為氧化性膽固醇對平滑肌細胞與對內皮細胞的毒性傷害所導致,氧化膽固醇亦會促進發炎反應和細胞壞死(necrosis)、增加發炎抑制及結腸癌等等。 我們發現在細胞存活率試驗(MTT assay)中,低濃度的氧化性膽固醇7-keto-cholesterol (7-keto)和Cholesterol-5 alpha, 6?alpha-epoxide (epoxide)會誘發人類臍帶靜脈內皮細胞的增生,且在體外管柱形成試驗(tube formation)以及wound healing試驗中發現7-keto和epoxide這?種氧化性膽固醇?會誘發人?臍帶靜脈內皮細胞?血管組織的形成以及細胞的增生與快速遷移。當觀察一些血管新生相關蛋白,如:mitogen-activated protein kinase (MAPK)之extracellular signal-regulated kinase (ERK)、c-Jun N-terminal kinase (JNK)、endothelial nitric oxide synthase (eNOS)以及adhension molecule,如:integrin時發現7-keto和epoxide誘發人?臍帶靜脈內皮細胞?血管組織的形成可能是經由integrin ?alpha (v)和beta?3蛋白質?調控。除此之外,我們也發現了7-keto和epoxide可增加MMP-2蛋白活性。以上結果證實了,氧化膽固醇中的7-keto和epoxide有促血管新生作用,這也是我們首次發現氧化膽固醇與血管新生之間的關係。 當進一步的研究7-keto和epoxide 誘發人類臍帶靜脈內皮細胞integrinalpha (v)和beta?3蛋白質的表現是經由哪些訊息傳遞時,我們發現一些kinase的抑制劑(inhibitor)以及抗氧化劑並不能抑制由7-keto及epoxide所誘發之integrin alpha (v)和beta 3蛋白質的表現。由結果得知MAP kinase kinase (MEK) inhibitor PD98059 (PD, 10 μM);JNK inhibitor SP600125 (SP, 10 μM);p38 MAPK inhibitor SB203580 (SB, 10 μM);PI3K inhibitor LY294002 (LY, 10 μM);PKC alpha inhibitor G?6976 (G?, 10 nM);PKC inhibitor rottlerin (rott, 10 μM);nitric oxide synthase inhibitor L-NAME (NAME, 100 μM);antioxidant N-Acetyl Cysteine (NAC) (NAC, 1 mM);antioxidant Tiron (Tiron, 1 mM);nuclear factor-kappa B (NF-kappa B) inhibitor PDTC (PDTC, 25 μM);peroxisome proliferator activator receptor gamma(PPAR gamma) agonist rosiglitaze (rosi, 10 μM);Ca2+ antagonist nifedipine (nifedipine, 50 μM)並不會影響由7-keto和epoxide所誘發HUVECs integrin alpha (v)和beta 3蛋白質表現;故推測7-keto和epoxide誘發HUVECs integrin alpha (v)和beta 3蛋白質表現非經由MAPK、phosphatidylinositol 3-kinase (PI3K)、protein kinase C (PKC)等之訊息傳遞路徑。 未來將利用反轉錄-聚合酵素連鎖反應(reverse transcription- polymerase chain reaction,RT-PCR)來研究7-keto和epoxide 是否會誘發人類臍帶靜脈內皮細胞integrin alpha (v)和beta 3 mRNA的表現,並更近一步的探討7-keto和epoxide誘發人類臍帶靜脈內皮細胞integrin alpha (v)和beta 3蛋白質的表現是經由哪些過程傳遞訊息。
URI
https://203.71.86.71/handle/123456789/12438
File(s)
No Thumbnail Available
Name

C0178739.pdf

Size

12.98 MB

Format

Adobe PDF

Checksum

(MD5):2ad1a48dbac7489ea4e01549bd39e7af

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback